TRAVASOL 8.5% W/O ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
When do Travasol 8.5% W/o Electrolytes patents expire, and when can generic versions of Travasol 8.5% W/o Electrolytes launch?
Travasol 8.5% W/o Electrolytes is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVASOL 8.5% W/O ELECTROLYTES is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Travasol 8.5% W/o Electrolytes
A generic version of TRAVASOL 8.5% W/O ELECTROLYTES was approved as amino acids by B BRAUN on April 13th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAVASOL 8.5% W/O ELECTROLYTES?
- What are the global sales for TRAVASOL 8.5% W/O ELECTROLYTES?
- What is Average Wholesale Price for TRAVASOL 8.5% W/O ELECTROLYTES?
Summary for TRAVASOL 8.5% W/O ELECTROLYTES
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TRAVASOL 8.5% W/O ELECTROLYTES at DailyMed |
US Patents and Regulatory Information for TRAVASOL 8.5% W/O ELECTROLYTES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVASOL 8.5% W/O ELECTROLYTES | amino acids | INJECTABLE;INJECTION | 017493-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
